Head-to-head · WeighScore
Ecka Health vs Effecty
By GLP-1 ScorecardUpdated
Score comparison
Effecty has the higher recorded score — 83.7/100 to 59.3/100.
Effecty grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Separate compounded/branded offers; confirm discounts, billing and exit terms.
Before you choose
Before comparing the headline prices, the Ecka Health review and the Effecty review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Ecka Health vs Gala Health and Eclipse Medical Wellness vs Effecty compare each of them with another graded program, and the list of alternatives to Ecka Health ranks the programs closest to Ecka Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Ecka Health | Effecty |
|---|---|---|
| WeighScore | 59.3/100 | 83.7/100 |
| Grade | C | B |
| Site position | #376 | #21 |
| Semaglutide | Advertised from $99/mo; pricing shown during the online visit, plan length not published | $170/month before code; advertised $95 first month. Supply unconfirmed. |
| Tirzepatide | Advertised from $199/mo; pricing shown during the online visit, plan length not published | $235/month before code; advertised $160 first month. Supply unconfirmed. |
| Coverage | Advertised as nationwide; no state list | Nationwide shipping claimed; confirm treatment-specific eligibility. |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #376 · C
Strengths
- Names its prescribing physicians
- Offers brand Zepbound alongside compounded options
- Shows a LegitScript seal
What to consider
- The real price appears only during the online visit
- No legal company name or address is published
- The semaglutide page never says whether the drug is compounded or brand, and the tirzepatide page still shows template placeholder text
- Approved orders are final and not refundable
Strengths
- Medication-specific billing terms
- Dose-independent pricing advertised
- Separate Wegovy offer published
What to consider
- Selected total/supply unconfirmed
- Prescription sales described as final
- Assigned pharmacy and individual credentials unverified
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.